Skip to content

Evaluation of Some Inflammatory Markers in Autism Spectrum Disorders

Evaluation of Some Inflammatory Markers in Autism Spectrum Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05803005
Enrollment
100
Registered
2023-04-07
Start date
2023-09-01
Completion date
2024-10-01
Last updated
2023-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Brief summary

Evaluate some Inflammatory markers \[IL-6, IL-8, TNF\_alpha\] in children with autism spectrum disorder

Detailed description

several studies have suggested a correlation between ASD and abnormal immune activation (9) For instance, there is a high incidence of autistic subjects in families with other autoimmune disorders such as celiac disease and rheumatoid arthritis, suggesting a potential role for immune dysfunction in the pathophysiology of ASD High levels of IL-6 in the brain could determine alterations of synapse formation, dendritic spine development, and neuronal circuit balance \[13\], while in plasma they have been associated with increased stereotypical behaviors and with regressive forms of ASD

Interventions

OTHERinflammatory marker in autism spectrum disorder

Evaluate some Inflammatory markers \[IL-6, IL-8, TNF\_alpha\] in children with autism spectrum disorder

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years

Inclusion criteria

* 50 patients aged 3\_18 years, equally sex distributed, who visit pediatric neurology outpatients clinic with autistic disorder at assiut university hospital will enrolled in this study and 50 controls . (According to DSM IV and ADT-R)

Exclusion criteria

* : Asperger syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), chronic seizures and recent infection and patients with congenital anomalies

Design outcomes

Primary

MeasureTime frameDescription
inflammatory marker in autismbaselineEvaluate some Inflammatory markers \[IL-6, IL-8, TNF\_alpha\] in children with autism spectrum disorder

Contacts

Primary Contactghada ali, graduated
doddamohamed96@gmail.com01060012214
Backup Contacteman fathalla, ass.prof
emangad2019@med.aun.edu.eg01115191158

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026